1 |
Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in south India- A retrospective approach |
|
|
| Kala Bahadur Rawal, Uday Venkat Mateti, Vijith Shetty, M.K. Unnikrishnan, C.S. Shastry |
|
| Clinical Epidemiology and Global Health. 2023; : 101333 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Incidence, Patterns, and Severity of Potential Drug Interactions Among Cancer Patients on Chemotherapy in a Tertiary Care Hospital |
|
|
| Anuradha H.V., Vinayak V. Maka, Prakash Patil, Anupama C. |
|
| Journal of Pharmacology and Pharmacotherapeutics. 2023; : 0976500X23 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Potential Drug-Drug Interactions Between Anti-Cancer Drugs and Other
Medications in Lung Cancer Patients: A Retrospective Study |
|
|
| Rosella Ayesha Pinto, Mahadev Rao, Arpita Roy, Levin Thomas, Karthik S. Udupa, Vasudeva Guddattu |
|
| Current Drug Safety. 2023; 18(2): 175 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Development of evidence-based indicators for the detection of drug-related problems among ovarian cancer patients |
|
|
| Kala Bahadur Rawal, Uday Venkat Mateti, Vijith Shetty, Chakrakodi Shashidhara Shastry, Mazhuvancherry Kesavan Unnikrishnan, Shraddha Shetty, Aparna Rajesh |
|
| Frontiers in Pharmacology. 2023; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Clinical pattern and drug-related problems among colorectal cancer patients at oncology center in Ethiopia: A hospital-based study |
|
|
| Belayneh Kefale, Melaku Tadege Engidaw, Desalegn Tesfa, Taklo Simeneh Yazie, Mulugeta Molla, Malede Berihun Yismaw |
|
| SAGE Open Medicine. 2022; 10: 2050312122 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital Cancer Unit, Uganda |
|
|
| Bonny Luzze, Barnabas Atwiine, Henry Mark Lugobe, Tadele Mekuriya Yadesa |
|
| BMC Cancer. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Potential drug-drug interactions and associated factors among admitted patients with psychiatric disorders at selected hospitals in Northwest Ethiopia |
|
|
| Ephrem Mebratu Dagnew, Asrat Elias Ergena, Samuel Agegnew Wondm, Ashenafi Kibret Sendekie |
|
| BMC Pharmacology and Toxicology. 2022; 23(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Potential drug–drug Interactions in hospitalized cancer patients: A report from the Middle-East |
|
|
| Azadeh Moghaddas, Mohammad Adib-Majlesi, Ali M Sabzghabaee, Ali Hajigholami, Rachel Riechelmann |
|
| Journal of Oncology Pharmacy Practice. 2021; 27(1): 46 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Drug therapy problems and health related quality of life among patients with colorectal cancer in a Kenyan tertiary health facility |
|
|
| Charles M Kabiru, Peter N Karimi, David G Nyamu, Irene W Weru |
|
| Journal of Oncology Pharmacy Practice. 2021; 27(2): 428 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients |
|
|
| Rashida Muhammad Umar, Sule Apikoglu-Rabus, Perran Fulden Yumuk |
|
| International Journal of Clinical Pharmacy. 2020; 42(2): 652 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Medication misuse in India: a major public health issue in India |
|
|
| G. Porter,N. Grills |
|
| Journal of Public Health. 2015; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Clinical pharmacists: The major support to Indian healthcare system in near future |
|
|
| PrasannaR Deshpande, Raghuram Vantipalli, CH Chaitanya Lakshmi, EJagadeswara Rao, Bishnu Regmi, Abdul Ahad, PSharmila Nirojini |
|
| Journal of Pharmacy And Bioallied Sciences. 2015; 7(3): 161 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors |
|
|
| Mª Ángeles Fernández de Palencia Espinosa,Mª Sacramento Díaz Carrasco,José Luis Alonso Romero,Amelia de la Rubia Nieto,Alberto Espuny Miró |
|
| International Journal of Clinical Pharmacy. 2015; 37(6): 1021 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Drug–drug interactions in HIV positive cancer patients |
|
|
| Brian Thabile Flepisi,Patrick Bouic,Gerhard Sissolak,Bernd Rosenkranz |
|
| Biomedicine & Pharmacotherapy. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East |
|
|
| Safoora Gholaminezhad,Molouk Hadjibabaie,Kheirollah Gholami,Mohammad Reza Javadi,Mania Radfar,Iman Karimzadeh,Ardeshir Ghavamzadeh |
|
| Annals of Hematology. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Potential drug–drug interactions at a referral hematology–oncology ward in Iran: a cross-sectional study |
|
|
| Molouk Hadjibabaie,Shirinsadat Badri,Sarah Ataei,Amir Hossein Moslehi,Iman Karimzadeh,Ardeshir Ghavamzadeh |
|
| Cancer Chemotherapy and Pharmacology. 2013; 71(6): 1619 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Medication surveillance on intravenous cytotoxic agents: a retrospective study |
|
|
| Brigit Oijen,Rob Janknegt,Hugo Wit,Frank Peters,Harry Schouten,Hugo Kuy |
|
| International Journal of Clinical Pharmacy. 2013; 35(4): 554 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Medication surveillance on intravenous cytotoxic agents: A retrospective study |
|
|
| Van Oijen, B. and Janknegt, R. and De Wit, H. and Peters, F. and Schouten, H. and Van Der Kuy, H. |
|
| International Journal of Clinical Pharmacy. 2013; 35(4): 554-559 |
|
| [Pubmed] [Google Scholar] |
|
19 |
Potential drug-drug interactions at a referral hematology-oncology ward in Iran: A cross-sectional study |
|
|
| Hadjibabaie, M. and Badri, S. and Ataei, S. and Moslehi, A.H. and Karimzadeh, I. and Ghavamzadeh, A. |
|
| Cancer Chemotherapy and Pharmacology. 2013; 71(6): 1619-1627 |
|
| [Pubmed] [Google Scholar] |
|